Due to a positive reception of the dosimeter products, Intellego and Likang have agreed to expand their collaboration to cover additional products in the disinfection industry in China and Asia. Intellego grants the exclusive sales and marketing rights in China for a product used in the disinfection market tied to minimum volumes totaling USD 360 million. The deal is contingent on market approval from regulatory agencies and other standard conditions, including product quality.

The parties do not foresee any significant regulatory obstacles, as the product has a low-risk classification, and most of the documentation is already in place. Intellego will have to continue to invest in the market together with Likang during the time period up until market launch and afterwards. The volumes will be achieved over a five-year period, with volumes increasing progressively over time.

The sales launch is projected to occur in late 2025.